2206. Pragmatic Assessment of Influenza Vaccine Effectiveness in the Department of Defense (PAIVED): Updates from Year 4 of a Multi-site Trial
Timothy Burgess(Uniformed Services University of the Health Sciences), Rhonda E Colombo(Henry M. Jackson Foundation), Stephanie A Richard(Henry M. Jackson Foundation), Bruce McClenathan(Womack Army Medical Center), Katrin Mende, Tahaniyat Lalani(Henry M. Jackson Foundation), Catherine M Berjohn(Henry M. Jackson Foundation), Christina Schofield(Madigan Army Medical Center), Wesley Campbell(Walter Reed National Military Medical Center), Alan L. Williams(Walter Reed National Military Medical Center), David Hrncir(Wilford Hall Ambulatory Surgical Center), Ana E Markelz(Uniformed Services University of the Health Sciences), Srihari Seshadri(Defense Health Agency), Anuradha Ganesan(Walter Reed National Military Medical Center), Christina Spooner(Defense Health Agency), Tyler Warkentien(Walter Reed National Military Medical Center), Limone Collins(Defense Health Agency), Jitendrakumar Modi(United States Naval Academy)
Cited by 3
Related Papers
Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza
|BMC Infectious Diseases|2015|514
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191
Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series
|The Lancet|2022|149
Infection-Associated Clinical Outcomes in Hospitalized Medical Evacuees After Traumatic Injury: Trauma Infectious Disease Outcome Study
|The Journal of Trauma: Injury, Infection, and Critical Care|2011|137
Biofilms and persistent wound infections in United States military trauma patients: a case–control analysis
|BMC Infectious Diseases|2014|98